ARBK vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

ARBK

60.2
AI Score
VS
ARBK Wins

HIVE

57.5
AI Score

Investment Advisor Scores

ARBK

60score
Recommendation
STRONG BUY

HIVE

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ARBK HIVE Winner
Forward P/E 100 62.8931 HIVE
PEG Ratio 0 0 Tie
Revenue Growth -74.7% 130.5% HIVE
Earnings Growth -94.0% -99.9% ARBK
Tradestie Score 60.2/100 57.5/100 ARBK
Profit Margin 32.8% -49.9% ARBK
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD ARBK

Relative Price Performance (Last 90 Days)

ARBK 1M: +1.0% · 3M: -23.6% HIVE 1M: -5.8% · 3M: -37.5%

Current Technical Phase

ARBK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $2.94

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.1 · Price: $2.83

Fundamentals Snapshot

Metric ARBK HIVE
Market Cap
Forward P/E 100.0 -6.0
Trailing P/E 0.6
Revenue (TTM)
Revenue Growth -0.7% 0.7%
Gross Margin 0.2% 0.4%
Operating Margin -3.9% -0.6%
EPS 5.07 -1.32
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ARBK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.